Abstract:Persistent bacterial infections pose a formidable threat to global health, contributing to widespread challenges in areas such as food safety, medical hygiene, and animal husbandry. Addressing this peril demands the urgent implementation of swift and highly sensitive detection methodologies suitable for point-of-care testing and large-scale screening. These methodologies play a pivotal role in the identification of pathogenic bacteria, discerning drug-resistant strains, and managing and treating diseases. Fortunately, new technology, the CRISPR/Cas system, has emerged. The clustered regularly interspaced short joint repeats (CRISPR) system, which is part of bacterial adaptive immunity, has already played a huge role in the field of gene editing. It has been employed as a diagnostic tool for virus detection, featuring high sensitivity, specificity, and single-nucleotide resolution. When applied to bacterial detection, it also surpasses expectations. In this review, we summarise recent advances in the detection of bacteria such as Mycobacterium tuberculosis (MTB), methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli ( E. coli ), Salmonella and Acinetobacter baumannii ( A. baumannii ) using the CRISPR/Cas system. We emphasize the significance and benefits of this methodology, showcasing the capability of diverse effector proteins to swiftly and precisely recognize bacterial pathogens. Furthermore, the CRISPR/Cas system exhibits promise in the identification of antibiotic-resistant strains. Nevertheless, this technology is not without challenges that need to be resolved. For example, CRISPR/Cas systems must overcome natural off-target effects and require high-quality nucleic acid samples to improve sensitivity and specificity. In addition, limited applicability due to the protospacer adjacent motif (PAM) needs to be addressed to increase its versatility. Despite the challenges, we are optimistic about the future of bacterial detection using CRISPR/Cas. We have already highlighted its potential in medical microbiology. As research progresses, this technology will revolutionize the detection of bacterial infections.

Recent advances in the CRISPR/Cas system-based visual detection method

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens

CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives

CRISPR-Cas based virus detection: Recent advances and perspectives

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

CRISPR-Cas based molecular diagnostics for foodborne pathogens

Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid

CRISPR-Cas- and Aptamer-based Systems for Diagnosing Pathogens: A Review

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

CRISPR molecular detection techniques: Advances from single to multiple detection methods

Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)

Versatile Detection with CRISPR/Cas System from Applications to Challenges

CRISPR Cas system: A strategic approach in detection of nucleic acids

Pathogen Detection Strategy Based on CRISPR

Ultrafast Visual Nucleic Acid Detection with CRISPR/Cas12a and Rapid PCR in Single Capillary

Recent progress on the CRISPR/Cas system in optical biosensors

Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application

Cas-based bacterial detection: recent advances and perspectives